Saturday, January 28, 2023

Tag: addyi

Addyi, the First “Female Viagra,” Rises Again

2
From The Hastings Center Report: "Addyi, a drug that made a splash when it was approved in the summer of 2015 as the first...

The Women’s Libido Pill is Back, and So is the Controversy

1
From Bloomberg: "The counterattack against the drug has been furious, and in many instances led by women. These forces contend that one woman’s sexual abnormal...

The Score is Even

1
From The Hastings Center: Three years ago, a pharmaceutical company created and funded a feminist group called Even the Score to campaign for FDA approval of...

“Some Drugs Won’t Help Most of Those Who Take Them”

1
“It’s the biggest secret in medicine,” said F. Perry Wilson, a researcher and physician at Yale University School of Medicine. “For the vast majority of...

“FDA Issues Guidelines for Female Libido Pills After Learning Some Hard...

1
From STAT: It “looks like the FDA is using this guidance to keep another company from trying to get a female sexual desire drug approved...

“It’s All In Her Bed (Or, Don’t Shoot the Massager)”

0
The drug watch blog Evidencer.org takes on Flibanserin (Addyi) the first drug claiming “to enhance women’s sexual drive…” Article →

Flibanserin’s ‘Effects’ Do Not Outweigh Harms, Review Finds

7
Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...

“Doctors on Social Media Fail to Disclose Conflicts of Interest”

0
“A STAT examination of hundreds of social media accounts maintained by health-care professionals finds that while they often tweet medical advice, they almost never disclose potential conflicts of...

“Study Shows Addyi is Not ‘Female Viagra’ by Any Stretch of...

1
Pharmaguy covers a study published in JAMA this month which found that Addyi, the new drug approved by the FDA to treat low sexual...

“Was Sexism Really Responsible for the FDA’s Hesitancy to Sign Off...

0
“The Food and Drug Administration’s approval of pharmaceutical treatment for low sexual desire in women has launched a heated debate over the dangers and benefits of medicalizing sex,” Maya Dusenbery writes in the Pacific Standard. Is “female Viagra” a feminist victory or a product of clever faux-feminist marketing by Big Pharma?

“Pass on the Pill or Pass Out” Campaign Warns Women About...

0
“The National Women’s Health Network launched the 'Pass on the Pink Pill – Or Pass Out' campaign, to warn women of the marginal benefits...

“New Pill for Boosting Female Libidos Off to a Slow Start”

1
Ed Silverman reports that only 80 prescriptions for Addyi, or Flibanserin, were filled in the drugs’ first two weeks on the market. Article →

“Controversial ‘Female Viagra’ Hits the Market, New Questions Arise”

1
Despite concerns about the drug’s necessity, effectiveness, and side-effects, Flibanserin (Addyi) has come to market as the first drug designed to increase sexual desire in women